CoChat

Sex Hormone-Binding Globulin in the Diagnosis of Peripheral Tissue Resistance to Thyroid Hormone: The Value of Changes after Short Term Triiodothyronine Administration*

SARNE, DAVID H., REFETOFF, SAMUEL, ROSENFIELD, ROBERT L., FARRIAUX, JEAN PAUL · 1988 · The Journal of Clinical Endocrinology & Metabolism
Cited by 94

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Thyroid hormone is one of several factors that modulate the level of sex hormone-binding globulin (SHBG) in serum. SHBG levels are usually elevated in thyrotoxicosis and have been reported to be normal in a few patients with generalized resistance to thyroid hormone (GRTH). This study was designed to determine whether basal serum SHBG levels or the SHBG response to short term T3 administration could be used as an index of thyroid hormone action and thus serve as a test for the evaluation of patients suspected of having peripheral tissue resistance to thyroid hormone. Serum SHBG, total T4, free T4 index (FT4I), total T3, and TSH levels were measured in 21 normal subjects, 28 hypothyroid patients, 20 thyrotoxic patients, and 10 patients with GRTH. Excluding patients with GRTH, serum basal SHBG values were correlated with FT4I values (r = 0.66; P < 0.0001). Mean SHBG levels in the patients with GRTH [37.6 ± 16.2 (±sd) nmol/L] were not significantly different from those in the normal subjects (35.1 ± 19.3 nmol/L) or hypothyroid patients (26.3 ± 17.1 nmol/L), but were significantly lower than those in the thyrotoxic group (64.7 ± 19.2 nmol/L; P < 0.001). All 10 patients with GRTH had basal SHBG values in the normal range, but 7 of 20 (35%) thyrotoxic patients also had normal basal SHBG values. T3 was given orally for three sequential 3-day periods at doses of 50,100, and 200 μg daily to 7 normal subjects, 11 hypothyroid and 3 thyrotoxic patients, and all 10 patients with GRTH. The serum SHBG concentration was measured on the last day at each dosage level. During T3 administration, SHBG levels increased in all individuals with normal tissue responsiveness. The increase above the basal value (ΔSHBG) at each T3 dose was similar in normal, hypothyroid, and thyrotoxic individuals (nonresistant subjects). After administration of 50 ng T3 daily, the mean ΔSHBG level was decreased [−2.9 ± 5.3 (±SD) nmol/L] in the resistant patients and increased (4.0 ± 4.9 nmol/L; P < 0.005) in the nonresistant subjects. After administration of 100 μg T3 daily, the mean ASHBG was −4.5 ± 6.8 nmol/L in the resistant patients and 8.6 ± 5.1 nmol/L (P < 0.0001) in the nonresistant subjects. Serum SHBG decreased by more than 2 nmol/L in 6 of 10 (60%) resistant patients, but in no nonresistant subject. After administration of 200 μg T3 daily, the mean ΔSHBG increase was 0.7 ± 7.3 nmol/L in the resistant patients and 16.6 ± 7.3 nmol/L (P < 0.0001) in the nonresistant subjects. Neither the combination of a normal basal serum SHBG value and elevated serum thyroid hormone values nor the relationship between serum SHBG and FT4I values was sufficient t o separate all GRTH patients from those with thyrotoxicosis. The combination of elevated serum thyroid hormone values and failure of serum SHBG to increase above the basal value after the administration of T3 for 6 days was found in 9 of 10 patients with GRTH but in none of the thyrotoxic subjects. The response of SHBG to T3 administration is useful in the demonstration of peripheral tissue resistance to thyroid hormone.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jcem-66-4-740

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 94

Metadata

Authors
SARNE, D. H., REFETOFF, S., ROSENFIELD, R. L., & FARRIAUX, J. P.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
1988-04
Volume
66
Issue
4
Pages
740-746
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2161200102
Cited by
94
References
1
FWCI
3.45
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.